share_log

HC Wainwright & Co. Maintains Buy on Inozyme Pharma, Maintains $16 Price Target

HC Wainwright & Co. Maintains Buy on Inozyme Pharma, Maintains $16 Price Target

HC Wainwright & Co.维持对Inozyme Pharma的买入,维持16美元的目标股价
Moomoo 24/7 ·  03/13 09:29

HC Wainwright & Co. analyst Edward White maintains Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $16 price target.

HC Wainwright & Co. 分析师爱德华·怀特维持Inozyme Pharma(纳斯达克股票代码:INZY)的买入并维持16美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发